•Lower response rate in EFR compared to the literature•IL-1 inhibitors as a treatment of choice in CAPS•IL-1 blockade as an therapeutic alternative in FMF, TRAP andMKD. Here, IL1B is linked to cryopyrin-associated periodic syndrome.